RESUMO
BACKGROUND: Iron deficiency anaemia is a public health problem. In case oral iron treatment is ineffective, poorly tolerated or contraindicated, the intravenous route becomes the first choice. The aim of the study was to evaluate the shift between ferrous gluconate (FG) and ferric carboxymaltose (FCM) usage at our hospitals over the years. We also performed a cost comparison between pre and post-FCM availability periods, taking into account the acquisition costs of both intravenous iron and red blood cell units (PRBC). STUDY DESIGN AND METHODS: The amount and costs of FG and FCM released by hospital Pharmacy Services from 2010 to 2019 were analysed, along with the number of transfused PRBC units in the same timeframe. RESULTS: Overall, the proportion of FCM usage rose from 8.6 % in 2014 to 71.9 % in 2019, as percentage of total intravenous iron released. After exclusion of haemodialysis, where FG is still widely used, the FCM use in the last four years raised from 12.9% to 92.5%. Despite the higher FCM cost, the mean yearly expenditure for intravenous iron plus PRBC units did not differ between pre- and post-FCM eras (2010-2013, 2,396,876 versus 2014-2019, 2,307,875 - pâ¯=â¯0.234), as a result of a net decrease of PRBC usage, namely from 15,083 to 12,654 (-16.1 %), respectively. DISCUSSION: Intravenous iron has a major role in treating iron deficiency anaemia in several settings. Third generation compounds are paving the way to more updated and safer treatments.
Assuntos
Anemia Ferropriva , Prescrições de Medicamentos/economia , Compostos Férricos , Compostos Ferrosos , Maltose/análogos & derivados , Administração Intravenosa , Anemia Ferropriva/tratamento farmacológico , Anemia Ferropriva/economia , Custos e Análise de Custo , Feminino , Compostos Férricos/administração & dosagem , Compostos Férricos/economia , Compostos Ferrosos/administração & dosagem , Compostos Ferrosos/economia , Humanos , Masculino , Maltose/administração & dosagem , Maltose/economiaRESUMO
Iron deficiency anemia is among the most frequent causes of disability. Intravenous iron is the quickest way to correct iron deficiency, bypassing the bottleneck of iron intestinal absorption, the only true mechanism of iron balance regulation in human body. Intravenous iron administration is suggested in patients who are refractory/intolerant to oral iron sulfate. However, the intravenous way of iron administration requires several precautions; as the in-hospital administration requires a resuscitation service, as imposed in Europe by the European Medicine Agency, it is very expensive and negatively affects patient's perceived quality of life. A new oral iron formulation, Sucrosomial iron, bypassing the normal way of absorption, seems to be cost-effective in correcting iron deficiency anemia at doses higher than those usually effective with other oral iron formulations. In this multicentric randomized study, we analyze the cost-effectiveness of intravenous sodium ferrigluconate vs oral Sucrosomial iron in patients with iron deficiency anemia refractory/intolerant to oral iron sulfate without other interfering factors on iron absorption.
Assuntos
Anemia Ferropriva/tratamento farmacológico , Compostos Férricos/uso terapêutico , Hematínicos/uso terapêutico , Administração Intravenosa , Administração Oral , Adulto , Idoso , Idoso de 80 Anos ou mais , Anemia Ferropriva/economia , Análise Custo-Benefício , Feminino , Compostos Férricos/administração & dosagem , Compostos Férricos/economia , Compostos Ferrosos/uso terapêutico , Hematínicos/administração & dosagem , Hematínicos/economia , Humanos , Masculino , Pessoa de Meia-Idade , Estudos ProspectivosRESUMO
Despite improvements in nutritional status, iron deficiency anemia (IDA) remains a debilitating nutritional problem worldwide. We estimate annual IDA prevalence rates by sex and age and the trends therein in Korea. We also calculate the health expenditures of IDA and its co-morbidities by analyzing claims data in the National Health Information Database from 2002 to 2013. All analyses were performed based on diagnosis codes of IDA (D50, D50.0, D50.8, and D50.9) regardless of whether IDA was the principal or a coexisting disease. Trends in IDA prevalence rates were evaluated by calculating annual percent changes (APCs) in prevalence. The health expenditures of IDA were calculated based on the direct medical costs (outpatient and hospitalization costs, pharmaceutical costs) and direct non-medical costs (travel costs). The overall IDA prevalence in both sexes increased approximately 2.3-fold from 2002 to 2013; the APC was +7.6%. In females, the prevalence of IDA was highest in aged 30-39 and 40-49 years. The APC was highest in those aged <10 years (+18.2%), followed by those aged ≥80 (+14.7%) and 70-79 (+9.8%) years. In males, the prevalence rates were highest in aged <10 years, followed by those aged ≥60 years. The APC was highest in those aged <10 years (+19.1%), followed by those aged ≥80 years (+10.5%). The total health expenditures increased 2.8-fold during 12 years. Diseases of the respiratory or gastrointestinal tract were the most prevalent co-morbidities in both males and females. The annual prevalence of IDA continues to rise in association with adverse health expenditures and co-morbidities in spite of improvements in nutritional status. Most importantly, infants and young children, the elderly, and females aged 30-49 years are at highest risk of IDA. A national, prospective, and well-organized effort to improve iron status and to manage IDA is required.
Assuntos
Anemia Ferropriva , Gastos em Saúde , Adulto , Idoso , Anemia Ferropriva/complicações , Anemia Ferropriva/economia , Anemia Ferropriva/epidemiologia , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Programas Nacionais de Saúde , Prevalência , Estudos Prospectivos , República da Coreia/epidemiologiaRESUMO
OBJECTIVE: To estimate the cost-effectiveness of price subsidies on fortified packaged complementary foods (FPCF) in reducing iodine deficiency, iron-deficiency anaemia and vitamin A deficiency in Pakistani children. DESIGN: The study proceeded in three steps: (i) we determined the current lifetime costs of the three micronutrient deficiencies with a health economic model; (ii) we assessed the price sensitivity of demand for FPCF with a market survey in two Pakistani districts; (iii) we combined the findings of the first two steps with the results of a systematic review on the effectiveness of FPCF in reducing micronutrient deficiencies. The cost-effectiveness was estimated by comparing the net social cost of price subsidies with the disability-adjusted life years (DALY) averted. SETTING: Districts of Faisalabad and Hyderabad in Pakistan. SUBJECTS: Households with 6-23-month-old children stratified by socio-economic strata. RESULTS: The lifetime social costs of iodine deficiency, iron-deficiency anaemia and vitamin A deficiency in 6-23-month-old children amounted to production losses of $US 209 million and 175 000 DALY. Poor households incurred the highest costs, yet even wealthier households suffered substantial losses. Wealthier households were more likely to buy FPCF. The net cost per DALY of the interventions ranged from a return per DALY averted of $US 783 to $US 65. Interventions targeted at poorer households were most cost-effective. CONCLUSIONS: Price subsidies on FPCF might be a cost-effective way to reduce the societal costs of micronutrient deficiencies in 6-23-month-old children in Pakistan. Interventions targeting poorer households are especially cost-effective.
Assuntos
Análise Custo-Benefício , Assistência Alimentar/economia , Alimentos Fortificados/economia , Fenômenos Fisiológicos da Nutrição do Lactente/economia , Micronutrientes/deficiência , Anemia Ferropriva/economia , Efeitos Psicossociais da Doença , Características da Família , Feminino , Humanos , Lactente , Iodo/deficiência , Masculino , Modelos Econômicos , Paquistão , Anos de Vida Ajustados por Qualidade de Vida , Deficiência de Vitamina A/economiaRESUMO
INTRODUCTION: Iron deficiency anaemia (IDA) is a major public health problem in India and especially harmful in early childhood due to its impact on cognitive development and increased all-cause mortality. We estimate the cost-effectiveness of price subsidies on fortified packaged infant cereals (F-PICs) in reducing IDA in 6-23-monthold children in urban India. MATERIALS AND METHODS: Cost-effectiveness is estimated by comparing the net social cost of price subsidies with the disability-adjusted life-years (DALYs) averted with price subsidies. The net social costs correspond to the cost of the subsidy minus the monetary costs saved by reducing IDA. The estimation proceeds in three steps: 1) the current lifetime costs of IDA are assessed with a health economic model combining the prevalence of anemia, derived from a large population survey, with information on the health consequences of IDA and their costs in terms of mortality, morbidity, and DALYs. 2) The effects of price subsidies on the demand for F-PICs are assessed with a market survey among 4801 households in 12 large Indian cities. 3) The cost-effectiveness is calculated by combining the findings of the first two steps with the results of a systematic review on the effectiveness of F-PICs in reducing IDA. We compare the cost-effectiveness of interventions that differ in the level of the subsidy and in the socio-economic strata (SES) eligible for the subsidy. RESULTS: The lifetime social costs of IDA in 6-23-month-old children in large Indian cities amount to production losses of 3222 USD and to 726,000 DALYs. Poor households incur the highest costs, yet even wealthier households suffer substantial losses. The market survey reveals that few households currently buy F-PICs, with the share ranging from 14% to 36%. Wealthier households are generally more likely to buy FPICs. The costs of the subsidies per DALY averted range from 909 to 3649 USD. Interventions targeted at poorer households are most effective. Almost all interventions are cost saving from a societal perspective when taking into account the reduction of future production losses. Return per DALY averted ranges between gains of 1655 USD to a cost of 411 USD. CONCLUSION: Price subsidies on F-PICs are a cost-effective way to reduce the social costs of IDA in 6-23-month-old children in large Indian cities. Interventions targeting poorer households are especially cost-effective.
Assuntos
Anemia Ferropriva/terapia , Grão Comestível/economia , Alimentos Fortificados/economia , Anemia Ferropriva/economia , Efeitos Psicossociais da Doença , Análise Custo-Benefício , Feminino , Financiamento Governamental , Humanos , Índia , Lactente , Masculino , Pobreza , Saúde Pública , Anos de Vida Ajustados por Qualidade de Vida , População UrbanaRESUMO
INTRODUCTION: Inadequate nutrition has a severe impact on health in India. According to the WHO, iron deficiency is the single most important nutritional risk factor in India, accounting for more than 3% of all disability-adjusted life years (DALYs) lost. We estimate the social costs of iron deficiency anemia (IDA) in 6-59-month-old children in India in terms of intangible costs and production losses. MATERIALS AND METHODS: We build a health economic model estimating the life-time costs of a birth cohort suffering from IDA between the ages of 6 and 59 months. The model is stratified by 2 age groups (6-23 and 24-59-months), 2 geographical areas (urban and rural), 10 socio-economic strata and 3 degrees of severity of IDA (mild, moderate and severe). Prevalence of anemia is calculated with the last available National Family Health Survey. Information on the health consequences of IDA is extracted from the literature. RESULTS: IDA prevalence is 49.5% in 6-23-month-old and 39.9% in 24-58-month-old children. Children living in poor households in rural areas are particularly affected but prevalence is high even in wealthy urban households. The estimated yearly costs of IDA in 6-59-month-old children amount to intangible costs of 8.3 m DALYs and production losses of 24,001 m USD, equal to 1.3% of gross domestic product. Previous calculations have considerably underestimated the intangible costs of IDA as the improved WHO methodology leads to a threefold increase of DALYs due to IDA. CONCLUSION: Despite years of iron supplementation programs and substantial economic growth, IDA remains a crucial public health issue in India and an obstacle to the economic advancement of the poor. Young children are especially vulnerable due to the irreversible effects of IDA on cognitive development. Our research may contribute to the design of new effective interventions aiming to reduce IDA in early childhood.
Assuntos
Anemia Ferropriva/economia , Anemia Ferropriva/epidemiologia , Efeitos Psicossociais da Doença , Deficiências de Ferro , Pré-Escolar , Feminino , Humanos , Índia/epidemiologia , Lactente , Masculino , Prevalência , Saúde Pública , Anos de Vida Ajustados por Qualidade de Vida , Fatores de Risco , População Rural , População UrbanaRESUMO
Iron deficiency is one of the most widespread nutritional disorders in both developing and industrialized countries, making it a global public health concern. Anemia, mainly due to iron deficiency, affects one third of the world's population and is concentrated in women and children below 5 years of age. Iron deficiency anemia has a profound impact on human health and productivity, and the effects of iron deficiency are especially pronounced in the first 1,000 days of life. This critical window of time sets the stage for an individual's future physiological and cognitive health, underscoring the importance of addressing iron deficiency in infants and young children. This review focuses on the use of fortified foods as a cost-effective tool for addressing iron deficiency in infants and young children in the Philippines.
Assuntos
Anemia Ferropriva/prevenção & controle , Análise Custo-Benefício , Alimentos Fortificados/economia , Deficiências de Ferro , Anemia Ferropriva/economia , Anemia Ferropriva/epidemiologia , Animais , Pré-Escolar , Cognição , Efeitos Psicossociais da Doença , Custos e Análise de Custo , Estudos de Viabilidade , Feminino , Alimentos em Conserva/economia , Custos de Cuidados de Saúde , Nível de Saúde , Humanos , Lactente , Recém-Nascido , Ferro da Dieta/administração & dosagem , Masculino , Leite/economia , Estado Nutricional , Filipinas/epidemiologia , Pobreza , GravidezRESUMO
Ever since the introduction of EPO, ESAs and iron dosing have been driven by financial incentives. When ESAs were a profit center for providers, large doses were used. With ESAs becoming a cost center, a new trend has appeared, gradually replacing their use with iron to achieve the same therapeutic effect at lower cost. This financially driven approach, treating ESAs and iron as alternatives, is not consistent with human physiology where these agents act in a complementary manner. It is likely that we are still giving unnecessarily large doses of ESAs and iron, relative to what our patients' true needs are. Although we have highlighted the economic drivers of this outcome, many other factors play a role. These include our lack of understanding of the complex interplay of the anemia of chronic disease, inflammation, poor nutrition, blood loss through dialysis, ESAs and iron deficiency. We propose that physiology-driven modeling may provide some insight into the interactions between erythropoiesis and ferrokinetics. This insight can then be used to derive new, physiologically compatible dosing guidelines for ESAs and iron.
Assuntos
Anemia Ferropriva , Eritropoetina/economia , Ferro/economia , Sistema de Pagamento Prospectivo/economia , Insuficiência Renal Crônica/complicações , Insuficiência Renal Crônica/economia , Anemia Ferropriva/tratamento farmacológico , Anemia Ferropriva/economia , Anemia Ferropriva/etiologia , Eritropoetina/uso terapêutico , Hematínicos/economia , Hematínicos/uso terapêutico , Humanos , Ferro/uso terapêutico , Diálise RenalRESUMO
OBJECTIVE: To examine the micronutrient status of disadvantaged pre-schoolers from Northeast Brazil, following the introduction of pro-poor policies, by assessing the prevalence of anaemia and micronutrient deficiencies and the role of sociodemographic factors, genetic Hb disorders and parasitic infections. DESIGN: In a cross-sectional study, data on sociodemographic status, health, growth, genetic Hb disorders, parasites and nutrient supply from day-care meals were obtained. Fasting blood samples were collected and analysed for Hb, serum ferritin, transferrin receptor, folate, vitamin B12, retinol, Zn and Se. SETTING: Seven philanthropic day-care centres serving urban slums in Salvador, Northeast Brazil. SUBJECTS: Pre-schoolers aged 3-6 years from disadvantaged households. RESULTS: Of the 376 sampled children, 94 % were of black or mixed race; 33 % and 29 % had at least one genetic Hb disorder and intestinal parasite, respectively. Stunting and underweight were ≤5 %; 14 % were overweight. Day-care centres supplied micronutrient-dense meals and snacks each weekday. Less than 10 % of pre-schoolers had anaemia and micronutrient deficiencies. Predictors (P < 0·05) of Hb were α(3·7) thalassaemia, Se and retinol (but not ferritin). Micronutrient predictors (P < 0·05) were: elevated α1-glycoprotein for ferritin, Hb AS and BMI Z-score >1 for transferrin receptor, Zn and elevated α1-glycoprotein for retinol, sex and helminths for Se, helminths for vitamin B12, and Giardia intestinalis infection for serum folate. CONCLUSIONS: Impaired growth, anaemia and micronutrient deficiencies were uncommon among these disadvantaged pre-schoolers attending day care. A range of interventions including provision of micronutrient-dense, fortified day-care meals, deworming and vitamin A supplementation likely contributed to improved micronutrient status, suggesting expanded coverage of these programmes.
Assuntos
Anemia Ferropriva/prevenção & controle , Fenômenos Fisiológicos da Nutrição Infantil , Deficiências Nutricionais/prevenção & controle , Assistência Alimentar , Alimentos Fortificados , Micronutrientes/uso terapêutico , Saúde da População Urbana , Anemia Ferropriva/economia , Anemia Ferropriva/epidemiologia , Anemia Ferropriva/etiologia , Brasil/epidemiologia , Criança , Creches , Desenvolvimento Infantil , Pré-Escolar , Estudos Transversais , Deficiências Nutricionais/economia , Deficiências Nutricionais/epidemiologia , Deficiências Nutricionais/etiologia , Dieta/efeitos adversos , Dieta/economia , Feminino , Serviços de Alimentação/economia , Alimentos Fortificados/economia , Humanos , Masculino , Micronutrientes/administração & dosagem , Micronutrientes/deficiência , Micronutrientes/economia , Estado Nutricional , Pobreza , Prevalência , Fatores Socioeconômicos , Saúde da População Urbana/economiaRESUMO
Iron anaemia and iron-deficient erythropoiesis are treated with oral iron supplements. For chronic haemodialysis or in the case of therapy failure or intolerance to oral iron therapy, intravenous supplements are administered. The costs of iron supplements borne by statutory health care insurance had strongly increased during the observation period from 2006 to 2010. Based on the invoice data of a large health insurance company with a market share of around 18 %, prescription data of iron preparations and laboratory tests were analysed and extrapolated to the Swiss population. During the 5-year observation period, costs of intravenous iron substitution increased by 16.5 m EUR (340.3 %) and the number of individuals treated by 243.5 %. A sharp rise was observed in women of menstruating age, which was mainly due to prescriptions issued by primary care physicians. More than 8 % of intravenous iron substitutions were administered without prior laboratory analysis,and must therefore be regarded as off-label use. A cost-benefit analysis is needed to demonstrate the additional value of intravenous over oral iron supplementation, and intravenous iron supplementation should be administered only to patients with proven iron deficiency.
Assuntos
Assistência Ambulatorial/economia , Anemia Ferropriva/tratamento farmacológico , Anemia Ferropriva/economia , Redução de Custos/economia , Custos de Medicamentos/estatística & dados numéricos , Compostos de Ferro/administração & dosagem , Programas Nacionais de Saúde/economia , Administração Oral , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Anemia Ferropriva/sangue , Anemia Ferropriva/epidemiologia , Criança , Pré-Escolar , Estudos Transversais , Feminino , Compostos Férricos/administração & dosagem , Compostos Férricos/economia , Óxido de Ferro Sacarado , Ferritinas/sangue , Ácido Glucárico/administração & dosagem , Ácido Glucárico/economia , Hemoglobinometria , Humanos , Lactente , Infusões Intravenosas/economia , Compostos de Ferro/economia , Masculino , Maltose/administração & dosagem , Maltose/análogos & derivados , Maltose/economia , Pessoa de Meia-Idade , Uso Off-Label/economia , Uso Off-Label/estatística & dados numéricos , Estudos Retrospectivos , Suíça , Adulto JovemRESUMO
BACKGROUND: Iron supplementation can be administered either intravenously or orally in patients with chronic kidney disease (CKD) and iron deficiency anaemia, but practice varies widely. The aim of this study was to estimate the health care costs and benefits of parenteral iron compared with oral iron in haemodialysis patients receiving erythropoiesis-stimulating agents (ESAs). METHODS: Using broad health care funder perspective, a probabilistic Markov model was constructed to compare the cost-effectiveness and cost-utility of parenteral iron therapy versus oral iron for the management of haemodialysis patients with relative iron deficiency. A series of one-way, multi-way and probabilistic sensitivity analyses were conducted to assess the robustness of the model structure and the extent in which the model's assumptions were sensitive to the uncertainties within the input variables. RESULTS: Compared with oral iron, the incremental cost-effectiveness ratios (ICERs) for parenteral iron were $74,760 per life year saved and $34,660 per quality-adjusted life year (QALY) gained. A series of one-way sensitivity analyses show that the ICER is most sensitive to the probability of achieving haemoglobin (Hb) targets using supplemental iron with a consequential decrease in the standard ESA doses and the relative increased risk in all-cause mortality associated with low Hb levels (Hb < 9.0 g/dL). If the willingness-to-pay threshold was set at $50,000/QALY, the proportions of simulations that showed parenteral iron was cost-effective compared with oral iron were over 90%. CONCLUSIONS: Assuming that there is an overall increased mortality risk associated with very low Hb level (<9.0 g/dL), using parenteral iron to achieve an Hb target between 9.5 and 12 g/L is cost-effective compared with oral iron therapy among haemodialysis patients with relative iron deficiency.
Assuntos
Anemia Ferropriva/tratamento farmacológico , Anemia Ferropriva/economia , Custos de Cuidados de Saúde/estatística & dados numéricos , Ferro/administração & dosagem , Ferro/uso terapêutico , Diálise Renal , Insuficiência Renal Crônica/terapia , Administração Intravenosa , Administração Oral , Adolescente , Adulto , Idoso , Anemia Ferropriva/epidemiologia , Comorbidade , Análise Custo-Benefício , Quimioterapia Combinada , Feminino , Hematínicos/uso terapêutico , Hemoglobinas/metabolismo , Humanos , Masculino , Pessoa de Meia-Idade , Anos de Vida Ajustados por Qualidade de Vida , Insuficiência Renal Crônica/epidemiologia , Adulto JovemRESUMO
BACKGROUND: Micronutrient deficiencies exact an enormous health burden on India. The release of the National Family Health Survey results--showing the relatively wealthy state of Gujarat having deficiency levels exceeding national averages--prompted Gujarat officials to introduce fortified wheat flour in their social safety net programs (SSNPs). OBJECTIVE: To provide a case study of the introduction of fortified wheat flour in Gujarat's Public Distribution System (PDS), Integrated Child Development Scheme (ICDS), and Mid-Day Meal (MDM) Programme to assess the coverage, costs, impact, and cost-effectiveness of the initiative. METHODS: India's 2004/05 National Sample Survey data were used to identify beneficiaries of each of Gujarat's three SSNPs and to estimate usual intake levels of vitamin A, iron, and zinc. Comparing age- and sex-specific usual intakes to Estimated Average Requirements, the proportion of the population with inadequate intakes was estimated. Postfortification intake levels and reductions in inadequate intake were estimated. The incremental cost of fortifying wheat flour and the cost-effectiveness of each program were estimated. RESULTS: When each program was assessed independently, the proportion of the population with inadequate vitamin A intakes was reduced by 34% and 74% among MDM and ICDS beneficiaries, respectively. Both programs effectively eliminated inadequate intakes of both iron and zinc. Among PDS beneficiaries, the proportion with inadequate iron intakes was reduced by 94%. CONCLUSIONS. Gujarat's substitution of fortified wheat flour for wheat grain is dramatically increasing the intake of micronutrients among its SSNP beneficiaries. The incremental cost of introducing fortification in each of the programs is low, and, according to World Health Organization criteria, each program is "highly cost-effective." The introduction of similar reforms throughout India would largely eliminate the inadequate iron intake among persons participating in any of the three SSNPs and would have a significant impact on the global prevalence rate of inadequate iron intake.
Assuntos
Farinha/análise , Serviços de Alimentação , Alimentos Fortificados/análise , Programas Governamentais , Micronutrientes/administração & dosagem , Anemia Ferropriva/economia , Anemia Ferropriva/epidemiologia , Anemia Ferropriva/etnologia , Anemia Ferropriva/prevenção & controle , Análise Custo-Benefício , Estudos Transversais , Países em Desenvolvimento , Farinha/economia , Serviços de Alimentação/economia , Alimentos Fortificados/economia , Programas Governamentais/economia , Pesquisa sobre Serviços de Saúde , Inquéritos Epidemiológicos , Humanos , Índia/epidemiologia , Micronutrientes/deficiência , Micronutrientes/economia , Prevalência , Deficiência de Vitamina A/economia , Deficiência de Vitamina A/epidemiologia , Deficiência de Vitamina A/etnologia , Deficiência de Vitamina A/prevenção & controle , Zinco/administração & dosagem , Zinco/deficiência , Zinco/economiaRESUMO
Although governments may decline to invest in iron fortification or supplementation influenced by the view that income growth will address the problem, the data do not support this view. Looking at the rates of anemia among children and adult women across 40 Demographic and Health Surveys from 32 countries, this study found that although anemia rates do decrease as income increases, the decrease is modest. Indeed, overall anemia rates decline roughly a quarter as fast as income increases and at only half the speed at which rates of underweight decline.
Assuntos
Anemia/prevenção & controle , Desenvolvimento Econômico/estatística & dados numéricos , Pobreza/estatística & dados numéricos , Adolescente , Adulto , Anemia Ferropriva/economia , Anemia Ferropriva/prevenção & controle , Transtornos da Nutrição Infantil/economia , Transtornos da Nutrição Infantil/prevenção & controle , Pré-Escolar , Demografia , Feminino , Política de Saúde , Humanos , Lactente , Transtornos da Nutrição do Lactente/economia , Transtornos da Nutrição do Lactente/prevenção & controle , Recém-Nascido , Masculino , Fenômenos Fisiológicos da Nutrição Materna , Análise de Regressão , Índice de Gravidade de Doença , Adulto JovemRESUMO
BACKGROUND: The reduction of maternal anemia is an agreed public health goal but one that has been very difficult to achieve. On Pemba Island, Tanzania, more than 90% of pregnant women are anemic, despite government efforts to identify and treat anemia during antenatal clinic visits. OBJECTIVE: To investigate the potential of private pharmacies to be accessed for iron supplements for maternal anemia. METHODS: We compared and contrasted the care given at private pharmacies and public clinics in terms of six characteristics: accuracy, affordability, availability, geographic accessibility, accommodation, and acceptability. We used data from in-depth interviews, surrogate customer encounters, governmental medicine record reviews, and participant observation. RESULTS: The accuracy of health care workers' advice about the treatment of anemia at private pharmacies and government clinics was similar. Supplements purchased at pharmacies were sometimes cheaper than the free supplements from the government, when the costs of transportation and time spent at the clinic were considered. Supplements at private pharmacies were always available, whereas the supply at government clinics was erratic. Private pharmacies were physically closer, socially less distant, and more accommodating than government clinics. Both clinics and private pharmacies were socially acceptable to pregnant women, although government clinics were typically not attended until later in pregnancy. CONCLUSIONS: The private sector probably has untapped potential for the reduction of maternal anemia in settings in which public health services fall short. Private pharmacies can contribute to the reduction of maternal anemia on Pemba Island and beyond.
Assuntos
Instituições de Assistência Ambulatorial/estatística & dados numéricos , Anemia Ferropriva/tratamento farmacológico , Acessibilidade aos Serviços de Saúde , Ferro/administração & dosagem , Farmácias/estatística & dados numéricos , Oligoelementos/administração & dosagem , Anemia Ferropriva/economia , Suplementos Nutricionais/economia , Feminino , Ácido Fólico/administração & dosagem , Acessibilidade aos Serviços de Saúde/economia , Humanos , Gravidez , Tanzânia , Complexo Vitamínico B/administração & dosagemRESUMO
OBJECTIVE: The present study examines the relationships of household food security status with Fe deficiency (ID) and Fe-deficiency anaemia (IDA) among children less than 3 years of age, and associated factors that contribute to ID and IDA. DESIGN: Cross-sectional study and chart review. The US Food Security Survey Module was administered to adult caregivers as part of the Children's Sentinel Nutrition Assessment Project (C-SNAP). Haematological data were obtained from medical records. SETTING: A large metropolitan medical centre in Minneapolis, Minnesota, USA. SUBJECTS: A multi-ethnic sample of 2853 low-income children aged <36 months who received care at the medical centre. RESULTS: Among the caregivers, 23.3 % reported low household food security and 11.6 % reported very low household food security (VLFS). After controlling for background factors, children from households with VLFS were almost twice as likely to have IDA than were children from households with high or marginal food security (OR = 1.98, 95 % CI 1.11, 3.53); the corresponding associations for ID were not statistically significant. CONCLUSIONS: The prevalence of IDA in early childhood is significantly larger in low-income infants and toddlers living in VLFS households. Asian, Hispanic and African-American children have elevated prevalences of ID and IDA. Breast-feeding may be associated with elevated ID and IDA, while participation in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) may be protective for ID.
Assuntos
Anemia Ferropriva/etiologia , Dieta/normas , Abastecimento de Alimentos/estatística & dados numéricos , Deficiências de Ferro , Desnutrição/complicações , Anemia Ferropriva/economia , Anemia Ferropriva/epidemiologia , Pré-Escolar , Estudos Transversais , Dieta/economia , Feminino , Abastecimento de Alimentos/economia , Humanos , Lactente , Ferro/economia , Masculino , Desnutrição/economia , Desnutrição/epidemiologia , Minnesota , Pobreza , Prevalência , Fatores de RiscoRESUMO
OBJETIVOS: Estimar los costos directos e indirectos de la deficiencia de hierro (DH) y la anemia ferropénica (AF) en Argentina y compararlos con los costos de un programa específico para su prevención y tratamiento. MÉTODOS: Análisis de escenario previo (ex ante) de la relación costo-beneficio de un programa de prevención y tratamiento de la AF dirigido a todos los niños y las embarazadas pobres y sin cobertura social de Argentina. Las consecuencias económicas de la DH y la AF se estimaron a partir de los costos directos - gastos vinculados a la atención de un parto prematuro - e indirectos - pérdidas en la productividad futura de los niños por su peor desarrollo cognitivo debido a la DH y la menor productividad de los adultos por la AF - mediante la metodología específica desarrollada por The Micronutrient Initiative. Las intervenciones se definieron según las Guías de Práctica Clínica vigentes en Argentina y los costos de los componentes se tomaron de los precios de las licitaciones del Ministerio de Salud de la Nación. RESULTADOS: Cada US$ 1,00 invertido en un programa de prevención y tratamiento de la DH y la AF, con una cobertura de 90 por ciento de la población de lactantes y embarazadas pobres sin seguro explícito de salud, representaría un ahorro de US$ 33,40 por la prevención de las pérdidas económicas debidas a estas enfermedades. CONCLUSIÓN: Las intervenciones para enfrentar la DH no solo mejoran significativamente el estado de salud de la población, sino que representan un ahorro considerable de recursos.
OBJECTIVES: To estimate the direct and indirect cost of iron deficiency (ID) and iron-deficiency anemia (IDA) in Argentina and compare it with the cost of a prevention and treatment program. METHODS: Analysis of a prior scenario to gage the relative cost-benefit of an IDA prevention and treatment program for all low-income children and expectant mothers without social coverage/benefits in Argentina. The economic consequences of ID and IDA were estimated as direct (cost of care for premature birth) and indirect costs (future lost productivity due to poor cognitive development due of children with ID and current reduced productivity of adults with IDA) employing the specific methodology designed by The Micronutrient Initiative (Ottawa, Canada). The interventions were defined according the practical clinical guidelines in use in Argentina and the item costs were taken from Ministry of Health price lists. RESULTS: Each US$ 1.00 invested in an ID and IDA prevention and treatment program, assuming 90 percent coverage of breastfeeding/pregnant uninsured low-income mothers, would save US$ 33.40 by preventing the economic losses that would otherwise result from these conditions. CONCLUSIONS: DH interventions not only significantly improve the health status of the population, but also offer a considerable savings.
Assuntos
Humanos , Feminino , Gravidez , Lactente , Adulto , Anemia Ferropriva/economia , Anemia Ferropriva/terapia , Ferro/deficiência , Anemia Ferropriva/epidemiologia , Argentina/epidemiologia , Análise Custo-Benefício , Distúrbios do Metabolismo do Ferro/economia , Distúrbios do Metabolismo do Ferro/epidemiologia , Distúrbios do Metabolismo do Ferro/terapiaRESUMO
RATIONALE: The National Service Framework advocates correction of anaemia in patients with chronic kidney disease (CKD). Oral iron is insufficient, while intravenous (IV) supplementation replenishes and maintains iron stores. In Yorkshire numerous peripheral clinics exist to reduce travel for patients, but patients must travel to the main unit for IV iron therapy. Therefore an outpatient service in tandem with a routine clinic for administration of IV CosmoFer was created. PURPOSE: To evaluate the feasibility and benefits of IV iron therapy in the outpatient clinic during active patient review for CKD patients. DESIGN: A cross-sectional study of patients attending for total dose IV iron (n = 57) at a peripheral clinic. Iron was administered and monitored according to protocol by one of the clinic nurses with medical staff available in the adjoining room. Haemoglobin, ferritin and renal function were recorded pre-infusion and after 4-6 months. Results are given as medians/means +/- standard error. RESULTS: A total of 76 IV infusions were carried out with no reported side effects or haemodynamic instability. Haemoglobin (median 10.9 vs. 11.3 g dL(-1), P = NS), creatinine and estimated glomerular filtration rate (eGFR) over the 6-month period remained stable. Serum ferritin rose significantly [80.9 +/- 6.2 vs. 186.4 +/- 18.2 g L(-1) (P < 0.001)]. Hospital time saved 380 day case bed hours, doctor hours saved 76 hours, and patient hours saved 3 hours/patient. Cost savings for TDI CosmoFer in peripheral clinic versus in centre therapy and versus sucrose, respectively, for 76 treatments was pound 5749.40 and pound 46,320.80 respectively. CONCLUSION: We have demonstrated, in a resource-limited service, the feasibility and cost-effectiveness of a management care pathway for patients with CKD, in a peripheral clinic, to receive total dose IV CosmoFer without disruption of a functioning renal clinic.
Assuntos
Instituições de Assistência Ambulatorial/organização & administração , Anemia Ferropriva/tratamento farmacológico , Anemia Ferropriva/etiologia , Eficiência Organizacional , Complexo Ferro-Dextran/uso terapêutico , Falência Renal Crônica/complicações , Instituições de Assistência Ambulatorial/economia , Anemia Ferropriva/economia , Análise Custo-Benefício , Estudos Transversais , Feminino , Ferritinas/sangue , Hemoglobinas/análise , Humanos , Infusões Intravenosas , Complexo Ferro-Dextran/administração & dosagem , Complexo Ferro-Dextran/economia , Testes de Função Renal , MasculinoRESUMO
Iron deficiency is the most common and widespread nutritional disorder in the world, affecting millions of people in both nonindustrialized and industrialized countries. We estimated the costs, effects, and cost-effectiveness of iron supplementation and iron fortification interventions in 4 regions of the world. The effects on population health were arrived at by using a population model designed to estimate the lifelong impact of iron supplementation or iron fortification on individuals benefiting from such interventions. The population model took into consideration effectiveness, patient adherence, and geographic coverage. Costs were based on primary data collection and on a review of the literature. At 95% geographic coverage, iron supplementation has a larger impact on population health than iron fortification. Iron supplementation would avert <12,500 disability adjusted life years (DALY) annually in the European subregion, with very low rates of adult and child mortality, to almost 2.5 million DALYs in the African and Southeast Asian subregions, with high rates of adult and child mortality. On the other hand, fortification is less costly than supplementation and appears to be more cost effective than iron supplementation, regardless of the geographic coverage of fortification. We conclude that iron fortification is economically more attractive than iron supplementation. However, spending the extra resources to implement iron supplementation is still a cost-effective option. The results should be interpreted with caution, because evidence of intervention effectiveness predominantly relates to small-scale efficacy trials, which may not reflect the actual effect under expected conditions.
Assuntos
Anemia Ferropriva , Análise Custo-Benefício/economia , Alimentos Fortificados/economia , Saúde Global , Compostos de Ferro/economia , Anemia Ferropriva/tratamento farmacológico , Anemia Ferropriva/economia , Anemia Ferropriva/epidemiologia , Criança , Feminino , Humanos , Compostos de Ferro/uso terapêutico , GravidezRESUMO
Iron deficiency anemia (IDA) depresses human productivity, but policymakers do not generally view this effect as an impediment to sustained economic growth. Economic logic should be enfolded in public advocacy for increased investment in the prevention and control of IDA. This paper argues that integrated strategies are required, with each intervention clearly related to particular groups at risk, and benefits carefully calibrated with costs. Protecting women's lives through supplementation has the first call on public resources, but the most productive investments reduce population prevalence at least cost, and these lie with food-based approaches within the competence of the processed food and seed industries. The public and private sectors must embark on modernization of the food industry in developing countries and reorientation of the international agricultural research complex so that iron-enriched essential foods will be affordable and accessible to the poor, especially children. The costs of IDA, the availability of cost-effective strategies and the benefits of sustained iron nutrition improvement to individuals, families and nations are reviewed. The roles of iron supplementation, food fortification, plant breeding and biotechnology, both actual and imminent, are described. The paper concludes that a recast Green Revolution directed toward dietary quality may be the key to enhancing the learning and earning capacity of young people in the developing world.